USD 1.6
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 156.00 USD | -46.94% |
2022 | 294.00 USD | -94.06% |
2021 | 4947.00 USD | -91.9% |
2020 | 61.07 Thousand USD | 12.31% |
2019 | 54.38 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 87.01 Thousand USD | 72.26% |
2024 Q1 | 50.51 Thousand USD | 32282.69% |
2023 Q2 | 2119.00 USD | -72.48% |
2023 Q3 | 225.00 USD | -89.38% |
2023 FY | 156.00 USD | -46.94% |
2023 Q1 | 7701.00 USD | 2519.39% |
2023 Q4 | 156.00 USD | -30.67% |
2022 Q3 | 3914.00 USD | 14396.3% |
2022 FY | 294.00 USD | -94.06% |
2022 Q4 | 294.00 USD | -92.49% |
2022 Q2 | 27.00 USD | -98.94% |
2022 Q1 | 2555.00 USD | -48.35% |
2021 Q4 | 4947.00 USD | -86.48% |
2021 Q1 | 72.08 Thousand USD | 18.02% |
2021 FY | 4947.00 USD | -91.9% |
2021 Q2 | 72.25 Thousand USD | 0.24% |
2021 Q3 | 36.57 Thousand USD | -49.38% |
2020 FY | 61.07 Thousand USD | 12.31% |
2020 Q4 | 61.07 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 54.38 Thousand USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Cell MedX Corp. | 46.12 Thousand USD | 99.662% |